Literature DB >> 24879979

Clinical features, diagnosis, and natural history of drug-induced liver injury.

Paul H Hayashi1, Robert J Fontana2.   

Abstract

Patients with idiosyncratic drug-induced liver injury (DILI) can pose substantial diagnostic, prognostic, and therapeutic challenges to the practicing gastroenterologist. The presentation of DILI may vary from asymptomatic liver enzyme elevation to acute liver failure. Although most DILI resolves following drug discontinuation, up to 20% of patients progress to chronic DILI further challenging the clinicians diagnostic and management skills. Also, some medications can lead to advanced fibrosis, encephalopathy, and portal hypertension without significant elevation in liver enzymes during exposure. Finally, there are no objective tests to definitively diagnose DILI. Although causality assessment instruments are available, none are widely accepted or used in clinical practice. Therefore, the diagnosis of DILI depends on thorough and accurate history taking, follow-up of the patient's clinical course and excluding more common causes of liver injury. In this review, we discuss the variable clinical presentations, course, and diagnostic methods used to establish a diagnosis and prognosis in DILI. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Year:  2014        PMID: 24879979     DOI: 10.1055/s-0034-1375955

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


  23 in total

1.  A Text Searching Tool to Identify Patients with Idiosyncratic Drug-Induced Liver Injury.

Authors:  Lauren Heidemann; James Law; Robert J Fontana
Journal:  Dig Dis Sci       Date:  2015-11-23       Impact factor: 3.199

2.  The Natural History of Severe Acute Liver Injury.

Authors:  David G Koch; J L Speiser; V Durkalski; R J Fontana; T Davern; B McGuire; R T Stravitz; A M Larson; I Liou; O Fix; M L Schilsky; T McCashland; J E Hay; N Murray; O S Shaikh; D Ganger; A Zaman; S B Han; R T Chung; R S Brown; S Munoz; K R Reddy; L Rossaro; R Satyanarayana; A J Hanje; J Olson; R M Subramanian; C Karvellas; B Hameed; A H Sherker; W M Lee; A Reuben
Journal:  Am J Gastroenterol       Date:  2017-04-25       Impact factor: 10.864

3.  Liver injury with novel oral anticoagulants: assessing post-marketing reports in the US Food and Drug Administration adverse event reporting system.

Authors:  Emanuel Raschi; Elisabetta Poluzzi; Ariola Koci; Francesco Salvo; Antoine Pariente; Maurizio Biselli; Ugo Moretti; Nicholas Moore; Fabrizio De Ponti
Journal:  Br J Clin Pharmacol       Date:  2015-05-20       Impact factor: 4.335

4.  Utility of a Computerized ICD-10 Algorithm to Identify Idiosyncratic Drug-Induced Liver Injury Cases in the Electronic Medical Record.

Authors:  Amoah Yeboah-Korang; Jeremy Louissaint; Irene Tsung; Sharmila Prabhu; Robert J Fontana
Journal:  Drug Saf       Date:  2020-04       Impact factor: 5.606

5.  Drug-induced liver injury: results from the hospital-based Berlin Case-Control Surveillance Study.

Authors:  Antonios Douros; Elisabeth Bronder; Frank Andersohn; Andreas Klimpel; Michael Thomae; Giselle Sarganas; Reinhold Kreutz; Edeltraut Garbe
Journal:  Br J Clin Pharmacol       Date:  2015-06       Impact factor: 4.335

Review 6.  Drug- and herb-induced liver injury: Progress, current challenges and emerging signals of post-marketing risk.

Authors:  Emanuel Raschi; Fabrizio De Ponti
Journal:  World J Hepatol       Date:  2015-07-08

7.  Drug-induced fulminant hepatic failure in pregnancy.

Authors:  Tabassum Firoz; Douglas Webber; Hilary Rowe
Journal:  Obstet Med       Date:  2015-09-15

8.  Causes, Features, and Outcomes of Drug-Induced Liver Injury in 69 Children from China.

Authors:  Yun Zhu; Yong-Gang Li; Jia-Bo Wang; Shu-Hong Liu; Li-Fu Wang; Yan-Ling Zhao; Yun-Feng Bai; Zhong-Xia Wang; Jian-Yu Li; Xiao-He Xiao
Journal:  Gut Liver       Date:  2015-07       Impact factor: 4.519

Review 9.  Case Characterization, Clinical Features and Risk Factors in Drug-Induced Liver Injury.

Authors:  Aida Ortega-Alonso; Camilla Stephens; M Isabel Lucena; Raúl J Andrade
Journal:  Int J Mol Sci       Date:  2016-05-12       Impact factor: 5.923

10.  Long-Term Outcomes After Drug-Induced Liver Injury.

Authors:  Paul H Hayashi; Einar S Bjornsson
Journal:  Curr Hepatol Rep       Date:  2018-07-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.